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Abstract: Retinol, the alcohol form of vitamin A is a key dietary component that plays a 
critical role in vertebrate development, cell differentiation, reproduction, vision and 
immune system. Natural and synthetic analogs of retinol, called retinoids, have generally 
been associated with the cell differentiation via retinoic acid which is the most potent 
metabolite of retinol. However, a direct function of retinol has not been fully investigated. 
New evidence has now emerged that retinol supports the self-renewal of stem cells 
including embryonic stem cells (ESCs), germ line stem cells (GSCs) and cancer stem cells 
(CSCs) by activating the endogenous machinery for self-renewal by a retinoic acid 
independent mechanism. The studies have also revealed that stem cells do not contain 
enzymes that are responsible for metabolizing retinol into retinoic acid. This new function 
of retinol may have important implications for stem cell biology which can be exploited for 
quantitative production of pure population of pluripotent stem cells for regenerative 
medicine as well as clinical applications for cancer therapeutics. 
Keywords: vitamin A; retinol; retinoic acid; embryonic stem cells; cancer stem cells;  
PI3 kinase signaling; OCT4; NANOG; SOX2; Insulin like growth factor 1 receptor (IGF1R) 
 
1. Introduction 
Vitamin A, a small dietary component of 286 Da size, discovered almost 100 years ago [1,2], is 
essential for vertebrate embryogenesis, normal growth and development [3–6] and its deficiency leads 
to reproductive failure in females [7]. It is a fat-soluble vitamin that belongs to the family of 
compounds which contains retinol and β-carotenes. 
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Vertebrates are unable to synthesize vitamin A which is generally acquired from carotenoids 
present in plants and through the food items absorbed from small intestine [8,9]. β-Carotene, also 
known as pro-vitamin A, is converted into vitamin A when additional levels are required. 
Retinol is the alcohol form of vitamin A. Studies of the past two decades have shown that retinol is 
associated with cell differentiation via its most potent metabolite retinoic acid [10]. Although the 
physiology of its metabolites retinaldehyde [11] and retinoic acid is studied in well details, a direct 
biological function of retinol itself has not been fully elucidated. Recent studies however, have provided 
new evidence that retinol has a direct retinoic acid independent function in stem cell biology [12–16] and 
metabolic fitness of mitochondria [17]. In this chapter, I will review studies on the direct retinoic acid 
independent function of vitamin A/retinol in stem cell biology and its potential applications in the 
regenerative medicine. For retinoic acid mediated function of vitamin A/retinol, readers are advised to 
refer to several elegant reviews by other authors [18–20]. I anticipate that this review will provoke new 
ideas and bring into sharp focus further studies on the exploration of vitamin A/retinol function in the 
cell biology. 
2. Retinol, Retinoic Acid and Cell Differentiation 
Vitamin A/retinol is generally stored in the liver as retinyl esters primarily in the form of retinyl 
palmitate [21]. The stored vitamin A/retinol is mobilized into blood plasma by the enzymes retinyl 
ester hydrolases (REHs) [22]. The normal concentration of retinol in blood plasma varies between  
1.0 and 2.0 μM [23]. 
The past two decades of research investigations have established that vitamin A/retinol executes its 
function via retinoic acid (Figure 1), and regulates the function of >500 genes involved in development 
and cell differentiation [24]. The circulating retinol in blood plasma binds to a 21 kDa retinol binding 
protein (RBP) also known as RBP4 and thyroxine binding-protein transthyretin (TTR) to form a 
ternary retinol-RBP-TTR complex in 1:1:1 molar proportion that binds to the target cell via cell 
surface receptor STRA6 (stimulated by retinoic acid 6) [25] for transport into the target cell. 
Inside the cytoplasm, vitamin A/retinol binds to a 15 kDa cellular retinol binding protein (CRBP) 
and is converted into retinoic acid by two sequential oxidation steps that convert first retinol into 
retinaldehyde and then to retinoic acid. Though the conversion of retinol into retinaldehyde is 
reversible, the retinoic acid cannot be reduced back to retinol. Retinol is converted into retinaldehyde 
by retinol dehydrogenases (Rdh10) whereas the enzymes that metabolize retinaldehyde into retinoic 
acid include retinaldehyde dehydrogenases Ralhd1 (Aldhd1), Ralhd2 (Alhd1A2) and Ralhd3 
(Alhd1A3) [26,27]. 
Retinoic acid is then transported to the nucleus where it binds to heterodimer receptors, retinoic 
acid receptor (RAR) and retinoid X receptor (RXR) which belong to the superfamily of  
ligand-inducible transcriptional regulators that include steroid hormone receptors, thyroid hormone 
receptors, and vitamin D3 receptors. This complex then binds to the retinoic acid responsive elements 
(RARE) in the promoter region of the retinoic acid-responsive genes to activate their expression [18–20]. 
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Figure 1. Model for retinol metabolism in a target cell: vitamin A/retinol (Rol) binds with 
the transthyretin (TTR) and retinol binding protein (RBP) to form a ternary complex that 
binds to STRA6 receptor on the surface of the target cell. Inside the cytoplasm, retinol 
binds to cellular retinol binding protein (CRBP) and is oxidized to retinaldehyde (RAL) by 
alcohol dehydrogenase (ADH4). RAL is then converted into retinoic acid (RA) by 
retinaldehyde dehydrogenases (RALDH). Retinoic acid isthen transported into the nucleus 
by binding to the cellular retinoic acid binding receptor (CRABP) where it forms a 
complex with RAR and RXR receptors that binds with retinoic acid response elements 
(RARE) in the promoter region of responsive genes to activate their expression. 
 
3. Retinol and Pluripotency of Embryonic Stem (ES) Cells 
In addition to its role in cell differentiation via retinoic acid, recent studies have demonstrated that 
vitamin A/retinol also has a direct function in the maintenance of self-renewal and prevention of 
differentiation of pluripotent stem cells [12–15]. These studies have demonstrated for the first time that 
vitamin A/retinol supports self-renewal of embryonic stem (ESCs) cells by elevating the expression of 
NANOG and OCT4, the critical transcription factors for the maintenance of pluripotency of ESCs [28]. 
Retinol executes its function by activating the phosphatidylinositol 3 (PI3) kinase signaling pathway 
via insulin like growth factor 1 (IGF1) receptor [12]. 
Mouse ESCs maintain their self-renewal in the presence of leukemia inhibitory factor (LIF) [29] but 
tend to differentiate spontaneously when LIF is removed from the medium. Other studies have shown that 
removal of LIF increases the metabolism of retinol into 4-hydroxyretinol and 4-oxoretinol by cytochrome 
P450 enzyme CYP26 (retinoic acid hydroxylase) with concomitant differentiation of ESCs without 
forming retinoic acid [30]. However, mouse ESCs treated with 0.2–0.5 μM retinol in the presence of LIF 
upregulated the expression of NANOG and OCT4 by 3–5 folds and prevented their differentiation [12]. 
Treatment of cells with LY294002, a potent inhibitor of PI3 kinase prevented the self-renewal of 
ESCs by retinol confirming the involvement of PI3 kinase signaling pathway [14]. The addition of 
inhibitors of various receptor tyrosine kinases such as AG1478, the inhibitor of epidermal growth 
factor receptor (EGFR) and picropodophyllin, the inhibitor of insulin like growth factor 1 receptor 
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(IGF1R) revealed that picropodophyllin prevented the upregulation of NANOG and OCT4 by retinol 
proving that retinol signaling is mediated via IGF1R. 
Further studies revealed that retinol signaling caused the activation of downstream effector of PI3 
kinase PKB/Akt by enhanced phosphorylation at threonine308 and serine473. The activation of 
PKB/Akt then led to the regulation of mammalian target of rapamycin (mTOR) that controls protein 
synthesis by phosphorylating ribosomal protein p70S6 kinase (S6K) and eukaryotic initiation factor 4E 
(eIF4E) binding protein (4E-BP1) which is crucial for the synthesis of components of translation 
apparatus [31]. Both mTORC1 and mTORC2 complexes were activated by the retinol signaling [14] 
(Figure 2). However, the mechanisms by which vitamin A/retinol activates IGF1R and upregulation of 
NANOG and OCT4 via PI3 kinase signaling forms an interesting area for future explorations. 
Figure 2. Model for retinol metabolism in ESCs: Vitamin A/retinol (Rol) activates PI3 
kinase in ESCs by engaging IGF1R via yet to be determined mechanism that leads to the 
activation of Akt/PKB via phosphorylation at serine308 and serine473 which then activates 
downstream targets mTORCI and mTORC2 complexes which ultimately results in the 
activation of pluripotent stem cell specific gene NANOG and OCT4. 
 
Contrary to its role in cell differentiation, Wang et al. [32] have revealed that short term exposure of 
murine ESCs to retinoic acid during early differentiation prevents spontaneous differentiation of these 
cells. The cells retain the capacity to differentiate into cardiomyocytes, neuronal cells and visceral 
endoderm, the derivatives of all three germ layers. Their studies also revealed that retinoic acid prevented 
the differentiation of ESCs by up regulating the expression of LIF, Wnt3a, Wnt5a, and Wnt6. Earlier 
studies by Miyabayashi et al. [33] on the other hand, have shown that Wnt/β-catenin/CBP signaling 
maintains the pluripotency of mouse ESCs. 
Mouse and rat ESCs can self-renew in a defined medium containing fetal calf serum and LIF in 
which mitogen activated protein kinases (MAPK) signaling is eliminated and the activity of glycogen 
synthases (GSK3) activity is blocked by dual inhibitors (2i) using PD0325901 and CHIR99021 
inhibitors [34]. Interestingly, retinol has no effect on GSK3 phosphorylation [11] or MAPK  
signaling (Chen and Khillan, unpublished results [35]). 
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4. Retinol and Proliferation of Germ Line Stem Cells (GSCs) 
Recent studies by Zhang et al. [15] have shown that vitamin A/retinol also supports the self-renewal 
of mouse GSCs. Their studies revealed that mGSCs proliferated faster in retinol medium and exhibited 
strong proliferation and colonization. Further, RNA and protein analyses revealed the upregulation of 
genes involved in cell proliferation such as proliferating cell nuclear antigen (PCNA), c-Myc,  
cyclin D1, cyclin A and CDK2. PCNA is a marker for the proliferative spermatogonia [36,37] and 
cyclin A and cyclin D1 are involved in regulating the cell cycle progression from G1 to S phase.  
c-Myc activation on the other hand, regulates the cell proliferation, cell growth, apoptosis, 
differentiation and stem cell self-renewal. 
The mGSCs cultured in retinol medium maintained pluripotency for over 18 passages as indicated 
by the high expression of NANOG, OCT4 and SOX2. Further, the mGSC colonies were also positive 
for cell surface markers of mouse ESCs such as SSEA1 and CD49f as well as Vasa, Stella and Dazl 
which are cell surface markers of mGSCs [38,39]. 
The pluripotency of mGSCs was further proven by teratoma formation after implantation into 
immunodeficient mice which contained derivatives of endodermal, mesodermal, and ectodermal 
embryonic germ layers including stratified cell epithelium, neuronal cells, cartilage, muscle, glandular 
structures, and endodermal high prismatic epithelium [15]. 
5. Retinol and Proliferation of Human ESCs 
Treatment of human ESCs with vitamin A/retinol resulted in excellent morphology of the 
undifferentiated colonies, i.e., even, thick, and big colonies. Also the number of undifferentiated colonies 
increased in the presence of retinol as accompanied by the decrease of differentiated colonies [40]. 
Vitamin A/retinol was further evaluated for its effect on the maintenance of undifferentiated human 
ESCs. Low concentrations such as 0.1–0.5 μM retinol had no effect on the self-renewal of human 
ESCs whereas 2.0 μM retinol enhanced their proliferation and induced the expression of human ESC 
specific markers. In the presence of 2.0 μM vitamin A/retinol, the colonies were noticeably larger  
as compared to control samples. Furthermore, vitamin A/retinol increased the expression of  
pluripotency-supporting genes, especially NANOG, which had a >20-fold relative expression level in 
the presence of 2.0–3.5 μM retinol. The effect of retinol was observed both at protein and mRNA 
expression of NANOG and OCT4 [40]. Flow cytometry analysis further confirmed the increase of 
stem cell markers TRA-160 and SSEA4 and revealed the increase in the number of cells expressing 
TRA-160 and SSEA4 by 43% and 63% respectively. 
6. Retinol and Amplification of Cancer Stem Cells (CSCs) 
CSCs comprise a rare population of cells in solid tumors that are believed to be responsible for 
tumor metastasis and relapse [41,42]. In spite of their discovery in acute mylogenous leukemia (AML) 
over fifteen years ago [43] and subsequent documented existence in many solid tumors including 
brain, lung, colon, prostate and breast tumors (Reviewed in [44]), the identity of CSC still remains 
questionable [45]. Tumor initiating cancer cells are generally isolated by cell sorting via flow 
cytometry using CD44+/CD24low/−, CD133+ and ESA+ cell surface markers or by aldehyde 
Nutrients 2014, 6 1214 
 
dehydrogenase 1 (ALDH1) using ALDEFLUOR florescent assay [44]. These markers however, are 
not exclusive to the CSCs and are expressed by non-CSCs as well [46,47] thus raising the doubts 
whether these cells represent “precursor stem cells” or the downstream progenitor cells. 
Vitamin A/retinol on the other hand, maintained the growth of undifferentiated cancer like stem 
cells from mouse mammary tumors in long term culture while eliminating the non-CSCs [16]. The 
cells exhibited indefinite capacity for self-renewal, expression of OCT4 and NANOG as well as 
mammary stem cell specific markers CD29 (β1-integrin) and CD49f (α6-integrin) [48]. Pure 
populations of putative CSCs could also be isolated from human breast cancer cell lines including 
MCF7, MBA MD231 and SUM159 cells (Khillan and Sharma personal communication). 
CSCs are believed to be resistant to conventional therapies such as radiation therapy and 
chemotherapy [49,50]. The cells isolated via retinol signaling therefore, showed resistance to radiation 
and chemo therapeutic agents and formed highly metastatic tumors after implantation into non-obese 
diabetic/severe combined immunodeficient (NOD/SCID) mice which is considered to be the gold 
standard test for CSCs. After differentiation, the cells expressed mammary specific markers such as  
β-casein and estrogen receptors [16]. 
7. Stem Cells and Impaired Retinol Metabolism 
Analysis of ESCs revealed that these cells are unable to metabolize retinol into retinoic acid [14]. 
As shown in Figure 1, retinol is transported into the cytoplasm of the target cell through the cell 
surface receptor STRA6 [25] where it binds to CRBP followed by metabolization into active ligand 
retinoic acid. Analysis of normal and retinol treated ESCs revealed the absence of Adh4, Adh1 and 
RALDH2 enzymes [14]. Further, ESCs also did not show the expression of STRA6 which indicates 
that the cells do not contain the receptors to transport vitamin A/retinol into the cell. Further 
investigations revealed that the cells do not express CRBP as well [14] suggesting that retinol may 
have extracellular function in these cells. Interestingly, similar analysis of CSCs also showed the 
absence of retinol metabolizing enzymes [16]. The lack of retinol metabolizing machinery therefore, 
suggests that stem cells do not have the capacity to synthesize retinoic acid which is further supported 
by the observations that addition of retinoic acid leads to their complete differentiation [13]. However, 
MassSpec analysis may be necessary to rule this out completely. 
The absence of expression of genes involved in vitamin A uptake from the blood may not be totally 
surprising as most cells that depend on vitamin A, do not take up vitamin A directly from the blood. 
Neurons in the adult brain for example which are not directly exposed to blood, depend on retinoic 
acid for regulating learning and memory as well as protein translation [51,52]. The cells that take up 
vitamin A are cells in the blood/brain barrier including choroid plexus. These cells express high levels 
of STRA6 receptor whereas neurons by themselves do not express genes involved in the vitamin A 
uptake. The photoreceptor cells in the eye that depend on vitamin A aldehyde as the chromophore to 
absorb light [53], are also not directly exposed to the blood due to the existence of blood/retina 
barriers. The vitamin A/retinol is therefore, absorbed by the RPE cells, which express STRA6 and take 
up a large amount of vitamin A/retinol. It is therefore, possible that the stem cells in stem cell niche 
which are not directly exposed to blood may not express the genes for vitamin A/retinol uptake. The 
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vitamin A/retinol in these cells may become available either via diffusion or from neighboring cells 
that take up the vitamin from blood, with the exception for hematopoietic stem cells. 
8. Purity of Stem Cell Population 
Retinol treatment of mouse ESCs and induced pluripotent stem cells (iPS) cells resulted in the 
elimination of differentiated cells leaving only pure population of undifferentiated cells [54] 
suggesting that the differentiated cells may have been eliminated via terminal differentiation due to 
their ability to metabolize retinol into retinoic acid. The undifferentiated characteristics of these cells 
were confirmed by generating chimeric animals via injection of cells into mouse blastocysts. The 
microinjection of cells resulted in the chimeric animals that exhibited high percentage of ESC 
contribution accompanied by germ line transmission of coat color of the ESCs [54]. 
9. Retinol and Mitochondrial Function 
Earlier, studies by Acin-Perez et al. [17] have revealed that vitamin A/retinol plays essential role in 
the metabolic fitness of the mitochondria. The cells deprived of vitamin A/retinol defaulted to basal 
levels of ATP synthesis which resulted in acute energy crisis. The cells recovered to significantly 
higher energy output as soon as the physiological level of retinol was restored without the need for 
conversion to other retinoids. c-Raf and protein kinase C (PKC) families of serine/threonine  
kinase [55] which plays critical role in mitochondrial biology, contain high affinity retinol binding 
sites in their regulatory domains [56]. PKCδ for example, contains high affinity binding sites for 
retinol in its zinc finger domain whereas, PKCδ/retinol complex signals the pyruvate dehydrogenase 
complex for enhanced flux of pyruvate into the Krebs cycle [17]. However, due to many isoforms, e.g., 
11 for PKC and 3 for Raf as target molecules, the complexity of the problem has proven to be 
overwhelming to investigate the function of individual target. The role of vitamin A/retinol in 
controlling the mitochondrial oxidative phosphorylation in relation to stem cell biology presents an 
interesting area for future investigations. 
10. Vitamin A and Reproduction 
The need for dietary vitamin A/retinol for normal spermatogenesis has been recognized for  
decades [57–60]. Wolbach and Howe [57] first observed that vitamin A deficient rodents suffered 
blindness and infertility disorders. Rats that are fed vitamin A/retinol free diet but containing the 
retinoic acid grow well but become blind [61] and infertile [62] without the exhibition of other signs 
associated with vitamin A deficiency (VAD). Females rats on the other hand, maintained only on 
retinoic acid diet became pregnant but the fetuses were invariably resorbed suggesting that vitamin A 
alcohol has specific functions which cannot be compensated by retinoic acid alone. 
Male rats maintained on only retinoic acid diet developed lesions in the reproductive tract. The rats 
also developed testicular changes such as sloughing of the cells of the germinal epithelium followed by 
an obliteration of the lumen of the tubule by Sertoli cells. However, the testicular regeneration was 
restored once the animals were fed diet containing vitamin A/retinol [58]. Withdrawal of retinol leads 
to arrest in the transition of A spermatogonia to A1 spermatogonia (reviewed in [63]). The normal 
Nutrients 2014, 6 1216 
 
spermatogenesis on the other hand, was restored when retinol was administered through diet [64,65] 
and the retinol treatment of VAD rats leads to synchronization of seminiferous tubules in the testis [66]. 
BMP4, a member of Bone morphogenetic proteins (BMPs) family has been implicated in 
spermatogenesis and germ cell survival [67]. Inactivation of BMP4 gene by gene targeting leads to the 
failure to form primordial germ cells (PGCs) [68]. It is also essential for PGC localization to the 
genital ridge and PGC survival [69]. BMP4 expression is significantly upregulated in testis of vitamin 
A deficient mice [70] which is down regulated by only retinol and not by retinoic acid. Further, germ 
cells utilize BMP4 intron 2 promoter in addition to classical 1A and 1B promoters. The decrease in 
BMP4 by retinol was found to be mediated by the 1A and intron 2 promoters [70]. Overall, the studies 
strongly support a direct role of vitamin A/retinol in reproduction. Further studies are needed to define 
this function at the molecular level. 
11. Conclusions 
Vitamin A/retinol is absorbed from food in the small intestine. It is stored in the liver from where it 
is mobilized into blood circulation bound to RBP4. Liver exhibits high affinity binding sites for RBP4 
however, it does not express STRA6 receptor [25]. Recent studies have identified a new receptor 
RBP4-receptor2 (RBPR2) which is primarily expressed in liver and intestine and is induced in adipose 
tissue of obese mice. It is structurally related to STRA6 and is highly conserved in vertebrates [71]. 
This receptor is believed to regulate retinol homeostasis in these tissues. STRA6, on the other hand has 
been shown to catalyze efficient retinol exchange between intracellular CRBPI and extracellular 
RBP4. This retinol influx and efflux by STRA6 may serve to refresh the intracellular retinol pool [72]. 
Many reports now provide evidence for a retinoic acid independent direct function of retinol both  
in vivo [57–67] and in vitro [12–17]. In addition, the studies by See et al. [73] have shown that all the 
late vitamin A deficiency (VAD)-induced malformations in rat could be prevented by the addition of 
retinol starting at E10.5, whereas provision of all trans retinoic acid throughout pregnancy only led to 
the improvement but failed to completely rescue the development of all organ systems. Collectively, 
these studies provide strong evidence for direct and retinoic acid independent function of vitamin 
A/retinol. The mechanism/s by which retinol executes its function however, remain poorly understood 
mainly due to the complexity of the in vivo systems. The results obtained in in vitro studies have 
limitation for directly extrapolating to in vivo data as the retinol in cell culture media can readily 
distribute to the cell membrane. Incidentally, the stem cells do not express STRA6 receptor [14] and 
the retinol metabolizing enzymes [14,16]. The expression of RBPR2 that confers high affinity RBP4 
binding and retinol transport [71] have not been reported on stem cells. Future studies will reveal how 
retinol interacts with stem cells to regulate cell proliferation and self-renewal. 
Retinoids, the natural and synthetic analogues of retinol, have been of significant interest as cancer 
preventive agents since late 1970s [74–76]. They have been used in many clinical trials to assess the 
role of β-carotene in cancer prevention. Almost 27 years ago, the first phase of β-Carotene and Retinol 
Efficacy Trial (CARET) among men and women at high risk of lung cancer was stopped early 
primarily due to an increased risk of lung cancer [75]. Similarly α-tocopherol and β-carotene (ATBC) 
and CARET study found an increased risk of lung cancer among those assigned to active β-carotene 
treatment [77] or no significant benefit of β-carotene [78]. On the other hand, β-carotene alone was 
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found to be associated with an increased risk of aggressive prostate cancer in a nested case-control 
study [79,80]. The outcome of these trials therefore, led some to question the safety of β-carotene 
supplementation for cancer prevention.  
In the light of recent observations of retinol function in the self-renewal of stem cells [12–15] and 
CSCs [16], the unexpected outcome of the above trials arouses curiosity whether vitamin A/retinol 
may have enhanced the amplification of CSCs. In context with the outcome of cancer trials, the 
absence of retinol metabolizing machinery in ESCs that share many properties with cancer cells 
evokes a provocative hypothesis that CSCs may also lack the capability to metabolize retinol [16]. 
Interestingly, ESC like molecular phenotype is enriched in tumor compared to normal tissue and 
association between an ESC like phenotype and poor prognosis is observed in breast, lung, bladder and 
brain tumors [81,82]. Overall, the studies described in this review support the hypothesis that stem 
cells in general may not have the capacity to metabolize retinol to retinoic acid. This may have major 
implications for regenerative medicine for isolating stem cells from adult tissue as well as CSCs from 
solid tumors for the identification of biomarkers and developing strategies for management of cancer 
for personalized therapeutics. This review therefore, brings into sharp focus the new directions and 
challenges for the investigators in the field of retinoids that need to be explored to delineate the 
mechanisms by which the alcohol form of vitamin A influences the biological functions without 
conversion into its acid metabolite. 
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